TY - GEN AU - Dreger,Peter AU - Schnaiter,Andrea AU - Zenz,Thorsten AU - Böttcher,Sebastian AU - Rossi,Marianna AU - Paschka,Peter AU - Bühler,Andreas AU - Dietrich,Sascha AU - Busch,Raymonde AU - Ritgen,Matthias AU - Bunjes,Donald AU - Zeis,Matthias AU - Stadler,Michael AU - Uharek,Lutz AU - Scheid,Christof AU - Hegenbart,Ute AU - Hallek,Michael AU - Kneba,Michael AU - Schmitz,Norbert AU - Döhner,Hartmut AU - Stilgenbauer,Stephan TI - TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial SN - 1528-0020 PY - 2013///0619 KW - Adult KW - Aged KW - Disease-Free Survival KW - Female KW - Follow-Up Studies KW - Hematopoietic Stem Cell Transplantation KW - methods KW - Humans KW - Leukemia, Lymphocytic, Chronic, B-Cell KW - genetics KW - Male KW - Middle Aged KW - Mutation KW - Phosphoproteins KW - RNA Splicing Factors KW - Receptor, Notch1 KW - Ribonucleoprotein, U2 Small Nuclear KW - Transplantation, Homologous KW - Treatment Outcome KW - Tumor Suppressor Protein p53 N1 - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't UR - https://doi.org/10.1182/blood-2012-11-469627 ER -